Search for: "Healthcare Collections LLC" Results 221 - 240 of 488
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2018, 9:00 am by Michael H Cohen
The challenge is that the healthcare venture managed by able healthcare entrepreneurs wants to call the shots. [read post]
16 Apr 2018, 8:35 am by Amber Walsh
Opportunities exist to actively engage patients which can lead higher collection rates. [read post]
6 Apr 2018, 6:08 am
Posted by Harvard Law School Forum on Corporate Governance & Financial Regulation, on Friday, April 6, 2018 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of March 30–April 5, 2018. [read post]
23 Mar 2018, 11:16 am by Amber Walsh
Davidson, Managing Director at Post Capital Partners LLC; Steven Goldsmith, Managing Director at Sterling National Bank; and Tom Schramski, PhD, CMAA, President and Managing Partner at Vertess Advisors LLC. [read post]
14 Feb 2018, 2:57 pm by Kevin LaCroix
The SEC alleged that Tilton and Patriarch were able to collect excessive management fees and retain control over their funds’ operation by failing to follow the valuation methodology that was laid out in their investment documents. [read post]
9 Feb 2018, 8:05 am by Aurora Barnes
Court of Appeals for the 6th Circuit itself, by employing rules of contract interpretation explicitly repudiated in Tackett to deem a general duration clause in the collective bargaining agreement ambiguous, and then using extrinsic evidence to hold the healthcare benefits of the retiree class vested for life. [read post]
2 Feb 2018, 11:16 am by John Elwood
United States Fish and Wildlife Service, 17-71, the smart money is counting Markle Interests, LLC. v. [read post]
17 Jan 2018, 8:51 am by John Elwood
The case concerns whether the healthcare benefits of CNH retirees have vested under the governing collective bargaining agreement. [read post]
26 Dec 2017, 6:39 am by Ben Vernia
According to DOJ’s press release: DaVita Rx LLC, a nationwide pharmacy that specializes in serving patients with severe kidney disease, agreed to pay a total of $63.7 million to resolve False Claims Act allegations relating to improper billing practices and unlawful financial inducements to federal healthcare program beneficiaries, the Justice Department announced today. [read post]
3 Dec 2017, 9:00 am by Julie LaVille Hamlet
Chemed Corporation and various of its subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation (collectively “Vitas”), recently settled allegations brought by the federal government that Vitas violated the False Claims Act by submitting to Medicare false claims for hospice services. [read post]